We provide senior, fractional leadership and advisory support to biotech and emerging pharma companies navigating early- and mid-stage development.
Our role is to bring experienced judgment to translational strategy, clinical design, and execution planning, helping teams reduce risk, improve decision quality, and avoid costly misalignment early in development.
Representative Areas of Focus
- Fractional Chief Medical Officer and clinical leadership
- Translational strategy and development planning
- Program reassessment or rescue
- IND through Phase 2 execution support